About
Beta radiation device
Areas of Focus
Categories
Uncategorized Medical DeviceRadiopharmaceuticalsAustralia
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
5
As Collaborator
1
Total Enrollment
1,689
By Phase
PHASE2: 1NA: 2
By Status
RECRUITING: 3COMPLETED: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06399172Lead Sponsor
OncoSil Pancreatic Cancer Post-marketing Clinical Registry - Italy
N/ANot yet recruiting
50 participants
Started: May 30, 2024 · Completed: Oct 30, 2029
NCT05466799Lead Sponsor
FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma
PHASE2Recruiting
80 participants
Started: Apr 26, 2023 · Completed: Sep 30, 2025
NCT04493632Lead Sponsor
OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
N/ARecruiting
500 participants
Started: Apr 12, 2022 · Completed: Oct 1, 2027
NCT03076216Lead Sponsor
A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.
NACompleted
9 participants
Started: Aug 1, 2017 · Completed: Nov 28, 2020
NCT03003078Lead Sponsor
A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane
NACompleted
50 participants
Started: Mar 27, 2017 · Completed: Jul 31, 2020
Locations (1)
Headquarters
Macquarie Park, Australia
Map
Loading map...